NANOVIRICIDES, INC. Key Metrics

2 years of history · ending 2025-06-30 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Working Capital Analysis

Valuation Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-1
Book Value Per Share
$0
Free Cash Flow Per Share
$-1
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
-99.7%
Return on Assets
-87.5%
Return on Invested Capital
-79.8%
Debt to Equity
Current Ratio
1.28
Quick Ratio
1.28
Asset Turnover
0.00
Working Capital
$364K
Net Current Asset Value
$371K
Invested Capital
$8M
OCF / Net Income
0.90
FCF / Net Income
0.90
Accruals Ratio (Sloan)
-11.2%
Net Debt
$-2M
Net Debt / EBITDA
0.18
Interest Coverage
-64373.46
Cash Coverage
-56903.89
Capex Coverage
-148.84
Tangible Common Equity
$7M
TCE / Total Assets
81.6%
NOPAT
$-8M
Cash ROIC
-89.9%
Capex / D&A
0.08
Reinvestment Rate
7.1%
Book Value 5Y CAGR
-19.1%
Stock Price (FY-end)
$1
Market Cap
$21M
P/B Ratio
2.82
P/TB Ratio
2.94
Enterprise Value
$20M
FCF Yield
-40.3%
Shareholder Yield
R&D Yield
26.2%
Capex Yield
0.3%
Shares Variation (YoY)
27.3%
Beta (5Y)
0.81
Cost of Equity
8.5%
Cost of Debt (after tax)
52W High
$2
52W Low
$1
Trailing Return 1Y
-23.1%
Trailing Return 5Y
-81.4%
F-Score (Piotroski)
1.00
Z-Score (Altman)
-17.38

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Stock Price on Earnings Dates